Patel Chem Specialities IPO

Incorporated in 2008, Patel Chem Specialities Limited (PCSL) manufactures and exports pharmaceutical excipients and specialty chemicals used in food, cosmetics, and industrial applications. Its products serve as binders, disintegrants, stabilisers, and thickeners. The company operates certified facilities in Vatva and Talod, with a 7,200 MT annual capacity across departments like R&D and packaging. It exports to East Asia, Europe, North America, and more. Key products include Rheollose®, Disolwell®, Swellcal®, and AmyloTab™. As of March 31, 2025, PCSL employs 136 people.

Patel Chem Specialities Limited IPO Overview

Patel Chem Specialities Limited is launching a book-built IPO worth ₹58.80 crore, consisting entirely of a fresh issue of 70 lakh equity shares. The IPO will open for subscription on 25 July 2025 and close on 29 July 2025, with the allotment expected to be finalised on 30 July 2025. The shares are proposed to be listed on the BSE SME platform on 1 August 2025. The price band is set at ₹82 to ₹84 per share. Investors can apply for a minimum lot size of 1,600 shares, with retail investors required to invest at least ₹2,62,400 for 3,200 shares, while the minimum HNI investment is ₹4,03,200 for 4,800 shares. Cumulative Capital Private Limited is the book-running lead manager, MUFG Intime India Private Limited (Link Intime) is the registrar, and Globalworth Securities Limited is acting as the market maker.

Patel Chem Specialities IPO Details

Patel Chem Specialities IPO Reservation

Patel Chem Specialities IPO Lot Size

Patel Chem Specialities IPO Promoter Holding

Patel Chem Specialities IPO Valuation Overview

Objectives of the Proceeds

• Funding capital expenditure requirements of the company – ₹43.14 cror

• General corporate purposes – Remaining proceeds

Key Financials (in ₹ Crore)